Payman Sattar, MD
Cardiovascular Disease · Chicago, ILNPI 1780609057
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.8%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Penumbra, Inc. at 38.3% of the total. Reporting peaked in 2019 at $2,689 and has fallen 92.4% since, to $204 in 2025.
Across 116 payments — averaging $78.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$3K
- Chiesi USA, Inc.$1K
- Boston Scientific$1K
- Abiomed$547
- Endologix LLC$540
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$453
- plus $2K from 19 others
Across 2 payments — averaging $935.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim$2K
- Medtronic$160
What the payments were for
- Consulting fees$901%
- Speaking & faculty fees$1,20013%
- Travel & lodging$2,37926%
- Food & beverage$5,45660%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 12 | $3,497 |
| Chiesi USA, Inc. | 1 | $1,200 |
| Boston Scientific | 13 | $1,116 |
| Abiomed | 6 | $547 |
| Endologix LLC | 4 | $540 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 29 | $453 |
| Novartis | 17 | $387 |
| Regeneron | 2 | $223 |
| Abbott | 4 | $214 |
| Medtronic(2 entities) | 5 | $164 |
| Amgen | 4 | $158 |
| Johnson & Johnson | 3 | $142 |
| Philips North America LLC | 1 | $114 |
| Cardiovascular Systems Inc. | 1 | $113 |
| Merck | 3 | $53 |
| W. L. Gore & Associates, Inc. | 2 | $34 |
| Shockwave Medical, Inc | 1 | $29 |
| Bayer | 1 | $20 |
| EKOS Corporation | 1 | $20 |
| Inari Medical, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| AstraZeneca | 1 | $17 |
| Cardinal Health 200 LLC | 1 | $15 |
| Terumo Medical Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$3,346
- JUXTAPID$1,200
- Watchman$757
- Impella$458
- Ovation$414
- PRALUENT$135
- ENTRESTO$118
- XARELTO$115
- Trilogy 100$114
- Coronary Orbital Atherectomy System$113
- Repatha$110
- GENERAL - STENTS$104
How this compares
$9,124 in reported general payments places this provider in the 80th percentile of 932 cardiovascular disease providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 32 | $25,532 |
| Metoprolol Succinate | 31 | $423 |
| Atorvastatin Calcium | 41 | $396 |
| Lisinopril | 19 | $55 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Chicago
- Sandeep NathanChicago$892K
- Boaz AvitallChicago$366K
- Akhil NarangChicago$363K
- Michael DavidsonChicago$317K
- Jyothy PuthumanaChicago$269K
- Sanjiv ShahChicago$246K
- Raja MutharasanChicago$146K
- Nitasha SarswatChicago$140K
- Evan SteinChicago$121K
- Dan FintelChicago$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.